Merck (MRK) Times Interest Earned (2011 - 2013)
Merck (MRK) reported Times Interest Earned of -$13.09 for Q1 2013, down 49.75% year-over-year from -$26.05 in Q1 2012, and up 11.98% quarter-over-quarter from -$14.87 in Q4 2012.
Merck (MRK) Times Interest Earned (2011 - 2013) Analysis & Trends
Merck (MRK) has 3 years of Times Interest Earned data on file, last reported at -$13.09 in Q1 2013.
- Times Interest Earned for Q1 2013 came in at -$13.09, down 49.75% year-over-year; the trailing twelve-month figure through Dec 2013 was -$62.01 (down 475.24% YoY), and the FY2012 annual result was $4.28, up 16.0% from the prior year.
- Times Interest Earned improved to -$13.09 in Q1 2013 per MRK's latest filing, from -$14.87 in the prior quarter.
- Over five years, Times Interest Earned peaked at -$8.33 in Q2 2012 and troughed at -$15.36 in Q2 2011.
- A 3-year average of -$12.23 and a median of -$12.53 in 2011 frame the typical range for Times Interest Earned.
- The sharpest annual moves came in 2012 and 2013: Times Interest Earned jumped 45.81% in 2012, then plunged 49.75% in 2013.
- A 3-year view of Times Interest Earned shows it stood at -$15.0 in 2011, then climbed by 0.84% to -$14.87 in 2012, then advanced by 11.98% to -$13.09 in 2013.
- Business Quant data shows MRK's Times Interest Earned at -$13.09 in Q1 2013, -$14.87 in Q4 2012, and -$10.78 in Q3 2012.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Gsk | 92,316,836.42 Bn | 92,316,831.46 Bn | 7.76 Bn | -13.73 |
| 2 | Eli Lilly | 983.57 Bn | 978.29 Bn | 16.22 Bn | - |
| 3 | Johnson & Johnson | 553.56 Bn | 531.50 Bn | 15.96 Bn | 23.39 |
| 4 | AbbVie | 383.35 Bn | 374.00 Bn | 10.78 Bn | - |
| 5 | Merck | 281.71 Bn | 276.06 Bn | 12.09 Bn | - |
| 6 | Amgen | 182.20 Bn | 170.16 Bn | 5.87 Bn | 4.06 |
| 7 | Gilead Sciences | 153.71 Bn | 145.98 Bn | 5.52 Bn | 10.78 |
| 8 | Pfizer | 143.75 Bn | 130.98 Bn | -1.21 Bn | - |
| 9 | Bristol Myers Squibb | 109.71 Bn | 99.25 Bn | 8.07 Bn | - |
| 10 | Novartis Ag | 108.28 Bn | 107.60 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2013 | -13.09 |
| Dec 31, 2012 | -14.87 |
| Sep 30, 2012 | -10.78 |
| Jun 30, 2012 | -8.33 |
| Mar 31, 2012 | -8.74 |
| Dec 31, 2011 | -15.00 |
| Sep 30, 2011 | -11.36 |
| Jun 30, 2011 | -15.36 |
| Mar 31, 2011 | -12.53 |